Phase II experience with toremifene in the treatment of ER-positive breast cancer of postmenopausal women.
Valavaara
R
R
Department of Radiotherapy and Oncology, University Central Hospital of Turku, Finland.
D000368:Aged; D001943:Breast Neoplasms / Q000032:analysis / Q000188:drug therapy*; D004341:Drug Evaluation; D004965:Estrogen Antagonists / Q000627:therapeutic use*; D005260:Female; D005387:Finland; D006801:Humans; D008875:Middle Aged; D015337:Multicenter Studies as Topic; D011960:Receptors, Estrogen / Q000032:analysis*; D013629:Tamoxifen / Q000031:analogs & derivatives* / Q000627:therapeutic use; D017312:Toremifene
D004965:Estrogen Antagonists; D011960:Receptors, Estrogen; D013629:Tamoxifen; D017312:Toremifene